课题基金 / 基金详情

Prostate Cancer: Impact of Fat & Flaxseed Modified Diet

Prostate Cancer: Impact of Fat & Flaxseed Modified Diet
前列腺癌:脂肪的影响
批准号:
6698051
负责人:
WENDY DEMARK-WAHNEFRIED
金额:
$30.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-01-04 至 2005-12-31

项目摘要

项目成果

WENDY DEMARK-WAHNEFRIED的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diet is presumed to play a major role in prostate cancer - a leading cancer among American men. Yet, to date there are no dietary interventions with proven efficacy for either prevention or complementary care. The proposed study will focus on flaxseed supplementation (FS) and a low fat diet (LF), since our pilot studies and the research of others suggest that these factors significantly alter prostate cancer progression. Our multidisciplinary team of nutritionists, urologists, pathologists and biostatistians propose a controlled clinical trial to test the effects of FS and LF on prostatic neoplasia and also explore potential hormonal mechanisms. Newly diagnosed, prostate cancer cases (N=160) who have greater than 3-week lag- time prior to prostatectomy will be block randomized into one of the following groups: 1) control; 2) FS (30 g/day); LF (less than or equal to 20 percent total energy); or 4) FS+LF. All subjects will be monitored and receive dietary instruction and supplies. Proliferation rate (MIB-1) will serve as the primary endpoint to determine diet efficacy. Other endpoints include: apoptotic index (TUNEL), extent of high grade prostatic intraepithelial neoplasia and total serum prostate specific antigen. Given our pilot data which suggest that FS and LF diets may operate via a hormonal mechanism, potential hormonal mediators also will be assessed [i.e., total serum testosterone, free androgen index, insulin-like growth factor-1 (IGF-1) and IGF binding protein-3]. Nutritional biomarkers (i.e., lignan levels in prostatic fluid and urine, and erythrocyte and prostate fatty acid profiles) also will be measured. Associations between nutritional biomarkers, hormonal mediators and study endpoints will be determined. The proposed study is structured to make an important contribution to what is known about diet and prostatic neoplasia. This research has the potential to expand the scope of complementary treatment offered for prostate cancer, and may provide a solid foundation for efforts aimed at prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prostate Cancer: Impact of Fat and Flaxseed Diets
  • 批准号:
    6974032
  • 项目类别:
  • 资助金额:
    $3.21万
  • 财政年份:
    2004
  • 负责人:
    WENDY DEMARK-WAHNEFRIED
  • 依托单位:
Promoting Health in Prostate and Breast Cancer Survivors (FRESH START)
  • 批准号:
    6974031
  • 项目类别:
  • 资助金额:
    $6.17万
  • 财政年份:
    2004
  • 负责人:
    WENDY DEMARK-WAHNEFRIED
  • 依托单位:
RENEW Research-out to Enhance Wellness Older Survivors
  • 批准号:
    6764705
  • 项目类别:
  • 资助金额:
    $60.28万
  • 财政年份:
    2004
  • 负责人:
    WENDY DEMARK-WAHNEFRIED
  • 依托单位:
STRENGTH: Survivor TRaining for ENhancinG Total Health
  • 批准号:
    6974025
  • 项目类别:
  • 资助金额:
    $2.37万
  • 财政年份:
    2004
  • 负责人:
    WENDY DEMARK-WAHNEFRIED
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: